 0 Table of Contents |
  1 Home |
  2 Information Standard |
  3 Data Model Overview |
  4 Data Exchange Overview |
  5 Change Log |
  6 Downloads |
  7 Artifacts Summary |
   7.1 ACP Questionnaire based on zib2020 |
   7.2 QuestionnaireResponse Hendrik Hartman 20201001 |
   7.3 QuestionnaireResponse Hendrik Hartman 20221108 |
   7.4 ACP Actor Consulter |
   7.5 ACP Actor Provider |
   7.6 Communication-reason-code |
   7.7 Advance Care Planning Procedure |
   7.8 AdvanceDirective |
   7.9 Communication |
   7.10 ContactPerson |
   7.11 Encounter |
   7.12 HealthProfessional Practitioner |
   7.13 HealthProfessional PractitionerRole |
   7.14 Medical Policy Goal |
   7.15 MedicalDevice |
   7.16 MedicalDevice Product ICD |
   7.17 Organ donation choice registration in donor register |
   7.18 Other Important Information |
   7.19 Patient |
   7.20 Position Regarding Euthanasia |
   7.21 Preferred Place Of Death |
   7.22 Specific Care Wishes |
   7.23 TreatmentDirective |
   7.24 ext Encounter Reference |
   7.25 ext LegallyCapable regarding medical treatment decisions |
   7.26 Euthanasia Statement |
   7.27 MedicalDevice ProductType ICD |
   7.28 Most Important Agreed-upon Goal of Medical Policy |
   7.29 Preferred Place Of Death |
   7.30 Yes, No, Unknown valueSet |
   7.31 F1 ACP ACPProcedure 01-10-2020 |
   7.32 F1 ACP Communication |
   7.33 F1 ACP ContactPerson Michiel Hartman |
   7.34 F1 ACP Donor Registration Yes |
   7.35 F1 ACP Encounter 01-10-2020 |
   7.36 F1 ACP HealthProfessional Practitioner Dr. van Huissen |
   7.37 F1 ACP HealthProfessional PractitionerRole Dr. van Huissen |
   7.38 F1 ACP Medical Policy Goal - Life-sustaining treatment |
   7.39 F1 ACP MedicalDevice ICD |
   7.40 F1 ACP MedicalDevice.Product ICD |
   7.41 F1 ACP Other Important Information |
   7.42 F1 ACP Patient Hendrik Hartman |
   7.43 F1 ACP Position Regarding Euthanasia Unknown |
   7.44 F1 ACP Preferred Place Of Death Unknown |
   7.45 F1 ACP Specific Care Wishes |
   7.46 F1 ACP TreatmentDirective |
   7.47 F1 ACP TreatmentDirective 116762002 |
   7.48 F1 ACP TreatmentDirective 281789004 |
   7.49 F1 ACP TreatmentDirective 305351004 |
   7.50 F1 ACP TreatmentDirective 32485007 |
   7.51 F1 ACP TreatmentDirective 40617009 |
   7.52 F1 ACP TreatmentDirective 89666000 |
   7.53 F2 ACP TreatmentDirective 305351004 |
   7.54 P2 ACP ACPProcedure 07-08-2025 |
   7.55 P2 ACP ACPProcedure 28-07-2024 |
   7.56 P2 ACP AdvanceDirective |
   7.57 P2 ACP Communication |
   7.58 P2 ACP ContactPerson Gert-Jan de Jong |
   7.59 P2 ACP ContactPerson Maya van der Sluijs-Mulder |
   7.60 P2 ACP Encounter 07-08-2025 |
   7.61 P2 ACP Encounter 28-07-2025 |
   7.62 P2 ACP HealthProfessional Practitioner Desiree Wolters |
   7.63 P2 ACP HealthProfessional Practitioner Santos |
   7.64 P2 ACP HealthProfessional PractitionerRole Desiree Wolters |
   7.65 P2 ACP HealthProfessional PractitionerRole Santos |
   7.66 P2 ACP Medical Policy Goal - Life-sustaining treatment |
   7.67 P2 ACP MedicalDevice ICD |
   7.68 P2 ACP MedicalDevice.Product ICD |
   7.69 P2 ACP Organ Donation Choice Registration 2025 08 07 |
   7.70 P2 ACP Other Important Information 2025 08 07 |
   7.71 P2 ACP Patient Samira van der Sluijs |
   7.72 P2 ACP Position Regarding Euthanasia 2025 08 07 |
   7.73 P2 ACP Preferred Place Of Death 2025 08 07 |
   7.74 P2 ACP Specific Care Wishes 2025 08 07 |
   7.75 P2 ACP TreatmentDirective 281789004 |
   7.76 P2 ACP TreatmentDirective 305351004 |
   7.77 P2 ACP TreatmentDirective 32485007 |
   7.78 P2 ACP TreatmentDirective 400231000146108 |
   7.79 P2 ACP TreatmentDirective 40617009-1 |
   7.80 P2 ACP TreatmentDirective 40617009-2 |
   7.81 P2 ACP TreatmentDirective 89666000 |
   7.82 P2 ACP TreatmentDirective other |